HUMAN METAPNEUMOVIRUS – BANGLADESH (02): (DHAKA) COMORBIDITIES, FATAL
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org
Date: Fri 17 Jan 2025
Source: The Daily Star [edited]
https://www.thedailystar.net/news/bangladesh/news/hmpv-infected-woman-comorbidity-dies-3800496
A 30-year-old woman diagnosed with human metapneumovirus (HMPV) and
multiple other health complications died at the Infectious Diseases
Hospital in Mohakhali on Wednesday [15 Jan 2025].
consultant at the hospital, told The Daily Star yesterday [16 Jan
2025] morning.
“She did not die solely from the HMPV infection. She had several
underlying conditions, including obesity, kidney issues, and lung
complications, as revealed by X-rays,” Ariful said.
[2025] first case of HMPV.
Homemaker [SA] had no history of travelling abroad. Her husband lives
abroad, but he has not visited the country recently. She hails from
Kishoreganj but used to live in Narsingdi.
Apart from HMPV, she tested positive for Klebsiella pneumoniae, a
variant of pneumonia, according to health officials.
Prof Md Sayedur Rahman, special assistant at the Ministry of Health
and Family Welfare, said based on scientific research so far, deaths
caused by the HMPV are extremely rare.
He said the deceased patient was initially affected by Klebsiella
pneumoniae and subsequently suffered multi-organ failure, which led
to her death. She had underlying conditions, obesity and thyroid
dysfunction.
He further emphasized that this virus typically does not cause death.
Individuals suffering from the flu should avoid public gatherings and
wear masks.
The symptoms of this virus resemble those of seasonal flu, including
cold, cough, body aches, and a runny nose. There is no significant
difference between this virus and regular flu, he said.
First identified in the Netherlands in 2001, HMPV spreads through
direct contact between people, or when someone touches a contaminated
surface.
Infections are most common during late winter and spring, and symptoms
range from mild cold-like illness to severe respiratory conditions,
such as bronchiolitis or pneumonia, according to the Institute of
Epidemiology, Disease Control and Research (IEDCR).
There is currently no vaccine or specific antiviral treatment for
HMPV. Management focuses on supportive care, including hydration,
fever reduction, and in severe cases, oxygen therapy or mechanical
ventilation. Most people recover on their own within 7 to 10 days,
according to the IEDCR.